QuidelOrtho Faces Strategic Shifts Amid Share Sale

Don't Miss our Black Friday Offers:

QuidelOrtho ( (QDEL) ) has shared an update.

QuidelOrtho Corporation is in the spotlight as Carlyle Group’s affiliated stockholder sells over 8 million shares in a secondary offering priced at $35.314 per share, with Goldman Sachs as the sole underwriter. This move, occurring as board members resign, reflects strategic shifts and highlights the complexities of market dynamics, offering intriguing insights for those interested in stock market maneuvers.

Find detailed analytics on QDEL stock on TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.